Abstract
Prevalence of autoantibodies against IA-2 (IA-2A), glutamic acid decarboxylase (GADA), and type II DNA topoisomerase (TopIIA) of Taiwanese type 1 diabetes mellitus (T1DM) patients was investigated. Correlations of these autoantibodies with patients' clinical manifestations were also analyzed. Prevalence of IA-2A, GADA, and TopIIA in our patients was 23.6%, 47.1%, and 55.2%, respectively. Eighty percent of the IA-2A recognized the carboxyl terminus of the IA-2 protein tyrosine phosphatase-like domain. Average disease duration of IA-2A+ patients was significantly shorter than that of IA-2A- patients [3.76+/-0.42 vs. 4.98+/-0.34 years, p = 0.028]. Presence of GADA was correlated with the mean age of onset [10.82+/-0.76 vs. 8.38+/-0.77 years for GADA+ and GADA- patients, p = 0.026]. Patients with adolescent onset have higher GADA prevalence and better residual beta-cell functions. TopIIA and GADA are suggested to be better markers for Taiwanese T1DM patients because of their higher prevalence and persistence.
References
Sep 13, 1990·Nature·S BaekkeskovP D Camilli
Nov 4, 1993·Nature·D L KaufmanP V Lehmann
Apr 1, 1995·The Journal of Clinical Investigation·W A HagopianA Lernmark
Feb 1, 1995·Clinical Immunology and Immunopathology·T TuomiI R Mackay
Apr 1, 1994·Diabetologia·C E GrubinA Lernmark
Nov 4, 1993·Nature·R TischH O McDevitt
Oct 1, 1993·Diabetologia·M KarvonenR LaPorte
Jan 1, 1993·The Journal of Clinical Investigation·M A AtkinsonN K Maclaren
Jan 1, 1993·Journal of Diabetes and Its Complications·P Z ZimmetS W Serjeantson
Apr 1, 1996·Diabetes·Y H ChangS T Tsai
Jul 1, 1996·Diabetes·C F VergeG S Eisenbarth
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·M S LanA L Notkins
Jun 1, 1996·Diabetes Care·C RattarasarnS Jaruratanasirikul
Nov 1, 1996·Diabetologia·J SeisslerW A Scherbaum
Jan 1, 1997·Diabetes·B ZhangA L Notkins
Dec 1, 1996·Endocrine Journal·Y OzawaT Saruta
Apr 1, 1997·Diabetes·U Wiest-LadenburgerW Richter
Nov 14, 1997·Diabetes·P J BingleyE A Gale
Dec 24, 1997·Clinical Endocrinology·L M ChuangB J Lin
Aug 1, 1997·Endocrine Journal·A KasugaT Saruta
Feb 3, 1998·Diabetologia·A C ThaiJ S Cheah
Apr 16, 1998·Diabetes Care·I YokotaY Kuroda
Aug 1, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·L HermitteB Vialettes
Sep 3, 1998·Diabetologia·J SeisslerW A Scherbaum
Feb 23, 1999·Diabetologia·R D LeslieA L Notkins
Sep 10, 1999·Diabetes Care·F MediciP Pozzilli
May 24, 2000·European Journal of Endocrinology·M Y ShiauY H Chang
Aug 29, 2000·Diabetes Research and Clinical Practice·S NakamotoT Saruta
Nov 15, 2000·Autoimmunity·M OhtaN Itoh
May 4, 2001·Human Immunology·M NishinoT Ogihara
Citations
Oct 30, 2007·Journal of Autoimmune Diseases·J J K LutaleK Vetvik
Nov 26, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Yi-Ching TungWen-Yu Tsai
Feb 22, 2012·Diabetes Research and Clinical Practice·Luong D LyKhue T Nguyen
Mar 25, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Hiroki HiraiAbner L Notkins
Oct 24, 2013·Journal of Proteomics·Shane MierschJoshua LaBaer
Feb 28, 2018·Pediatric Diabetes·Jieyuan CuiLin Zhang
Apr 18, 2018·Oncotarget·Bi-Wen ChengYann-Jinn Lee
Jul 15, 2021·Journal of Diabetes Research·Kun LinQiong Zeng
Jun 26, 2010·Journal of Proteome Research·Kazuhiro MatsuokaTatsuya Sawasaki
Oct 7, 2021·Diabetic Medicine : a Journal of the British Diabetic Association·Anna E LongClaire L Williams